학술논문
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study
Document Type
Article
Author
Bromberg, J.E.C.; van den Bent, M.J.; Issa, S.; van der Holt, B.; Abrahamse-Testroote, M.C.J.; van der Meulen, M.; Dirven, L.; Minnema, M.C.; Seute, T.; Durian, M.; Cull, G.; van der Poel, M.W.M.; Stevens, W.B.C.; Zijlstra, J.M.; Brandsma, D.; Nijland, M.; Mason, K.D.; Beeker, A.; de Jong, D.; Doorduijn, J.K.
Source
In: Neuro-Oncology . (Neuro-Oncology, 1 April 2024, 26(4):724-734)
Subject
Language
English
ISSN
15235866
15228517
15228517